Current concept of abdominal sepsis: WSES position paper

World Journal of Emergency Surgery

Volumn 9, Issue 1, 2014, Pages

  Sartelli, Massimo ^a   Catena, Fausto ^b   Di Saverio, Salomone ^c   Ansaloni, Luca ^d   Malangoni, Mark ^e   Moore, Ernest E ^f   Moore, Frederick A ^g   Ivatury, Rao ^h   Coimbra, Raul ⁱ   Leppaniemi, Ari ^j   Biffl, Walter ^f   Kluger, Yoram ^k   Fraga, Gustavo P ^l   Ordonez, Carlos A ^m   Marwah, Sanjay ⁿ   Gerych, Igor ^o   Lee, Jae G ^p   Tranà, Cristian ^a   Coccolini, Federico ^d   Corradetti, Francesco ^a   Kirkby Bott, James ^q   more..

^a Macerata Hospital   (Italy)

^b Maggiore Parma Hospital   (Italy)

^c MAGGIORE HOSPITAL   (Italy)

^d PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^e American Board of Surgery   (United States)

^f DENVER HEALTH MEDICAL CENTER   (United States)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^h VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^j HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^k Department of General Surgery Rambam Health Care Campus ^*  (Israel)

^l UNIVERSITY OF CAMPINAS   (Brazil)

^m UNIVERSIDAD DEL VALLE   (Colombia)

ⁿ POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^o DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^p Yonsei University College of Medicine   (South Korea)

^q UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899115910     PISSN: None     EISSN: 17497922     Source Type: Journal    
DOI: 10.1186/1749-7922-9-22     Document Type: Review

References (140)

1. Mazuski JE, Solomkin JS. Intra-abdominal infections. Surg Clin North Am 2009, 89(2):421-437. 10.1016/j.suc.2008.12.001, 19281892.
2. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical data. Clin Infect Dis 2005, 41(Suppl 5):S354-S367.
3. Merlino JI, Malangoni MA, Smith CM, Lange RL. Prospective randomized trials affect the outcomes of intraabdominal infection. Ann Surg 2001, 233(6):859-866. 10.1097/00000658-200106000-00017, 1421330, 11371744.
4. Mazuski JE, Sawyer RG, Nathens AB, DiPiro JT, Schein M, Kudsk KA, Yowler C. Therapeutic agents committee of the surgical infections society. The surgical infection society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt) 2002, 3(3):175-233. 10.1089/109629602761624180, 12542923.
5. Sartelli M, Catena F, Ansaloni L, Leppaniemi A, Taviloglu K, van Goor H, Viale P, Lazzareschi DV, Coccolini F, Corbella D, de Werra C, Marrelli D, Colizza S, Scibè R, Alis H, Torer N, Navarro S, Sakakushev B, Massalou D, Augustin G, Catani M, Kauhanen S, Pletinckx P, Kenig J, di Saverio S, Jovine E, Guercioni G, Skrovina M, Diaz-Nieto R, Ferrero A, et al. Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study. World J Emerg Surg 2012, 7(1):36. 10.1186/1749-7922-7-36, 3539964, 23190741.
6. LaRosa SP. Sepsis: Menu of new approaches replaces one therapy for all. Cleve Clin J Med 2002, 69:65-73. 10.3949/ccjm.69.1.65, 11811722.
7. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2001, 2003(31):1250-1256.
8. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. American college of chest physicians/society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidlines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
9. Jones AE, Yiannibas V, Johnson C, Kline JA. Emergency department hypotension predicts sudden unexpected in-hospital mortality: a prospective cohort study. Chest 2006, 130:941-946.
10. Esteban A, Frutos-Vivar F, Ferguson ND, Peñuelas O, Lorente JA, Gordo F, Honrubia T, Algora A, Bustos A, García G, Diaz-Regañón IR, de Luna RR. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007, 35(5):1284-1289. 10.1097/01.CCM.0000260960.94300.DE, 17414725.
11. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R. Surviving sepsis campaign guidelines committee including the pediatric subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39(2):165-228. 10.1007/s00134-012-2769-8, 23361625.
12. Tsukada K, Katoh H, Shiojima M, Suzuki T, Takenoshita S, Nagamachi Y. Concentrations of cytokines in peritoneal fluid after abdominal surgery. Eur J Surg 1993, 159:475-479.
13. Patel RT, Deen KI, Youngs D, Warwick J, Keighley MR. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994, 81:1306-1308. 10.1002/bjs.1800810914, 7953393.
14. Damas P, Ledoux D, Nys M, Vrindts Y, de Groote D, Franchimont P, Lamy M. Cytokine serum level during severe sepsis in human. Il6 as a marker of severity. Ann Surg 1992, 215:356-362. 10.1097/00000658-199204000-00009, 1242452, 1558416.
15. Holzheimer RG, Schein M, Wittmann DH. Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. Arch Surg 1995, 130:1314-1319. 10.1001/archsurg.1995.01430120068010, 7492280.
16. Cavaillon JM, Munoz C, Fitting C, Misset B, Carlet J. Circulating cytokines: the tip of the iceberg?. Circ Shock 1992, 38(2):145-152.
17. Martineau L, Shek PN. Peritoneal cytokine concentrations and survival outcome in an experimental bacterial infusion model of peritonitis. Crit Care Med 2000, 28(3):788-794. 10.1097/00003246-200003000-00030, 10752831.
18. Hendriks T, Bleichrodt RP, Lomme RM, de Man BM, van Goor H, Buyne OR. Peritoneal cytokines predict mortality after surgical treatment of secondary peritonitis in the rat. J Am Coll Surg 2010, 211:263-270. 10.1016/j.jamcollsurg.2010.03.038, 20670866.
19. Riché F, Gayat E, Collet C, Matéo J, Laisné MJ, Launay JM, Valleur P, Payen D, Cholley BP. Local and systemic innate immune response to secondary human peritonitis. Crit Care 2013, 17(5):R201. 10.1186/cc12895, 24028733.
20. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013, 369(9):840-851. 10.1056/NEJMra1208623, 23984731.
21. Sartelli M, Viale P, Catena F, Ansaloni L, Moore E, Malangoni M, Moore FA, Velmahos G, Coimbra R, Ivatury R, Peitzman A, Koike K, Leppaniemi A, Biffl W, Burlew CC, Balogh ZJ, Boffard K, Bendinelli C, Gupta S, Kluger Y, Agresta F, di Saverio S, Wani I, Escalona A, Ordonez C, Fraga GP, Junior GA, Bala M, Cui Y, Marwah S, et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg 2013, 8(1):3. doi:10.1186/1749-7922-8-3, 10.1186/1749-7922-8-3, 3545734, 23294512.
22. Emmi V, Sganga G. Diagnosis of intra-abdominal infections: clinical findings and imaging. Infez Med 2008, 16(Suppl 1):19-30.
23. Jaramillo EJ, Treviño JM, Berghoff KR, Franklin ME. Bedside diagnostic laparoscopy in the intensive care unit: a 13-year experience. JSLS 2006, 10(2):155-159. 3016143, 16882411.
24. Ceribelli C, Adami EA, Mattia S, Benini B. Bedside diagnostic laparoscopy for critically ill patients: a retrospective study of 62 patients. Surg Endosc 2012, 26(12):3612-5. 10.1007/s00464-012-2383-4, 22710654.
25. Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010, 54(11):4851-4863. 10.1128/AAC.00627-10, 2976147, 20733044.
26. Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, Pérez XL, Sirvent JM, Edusepsis Study Group Edusepsis study group: effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 2009, 180:861-866. 10.1164/rccm.200812-1912OC, 19696442, Edusepsis Study Group.
27. Castellanos-Ortega A, Suberviola B, García-Astudillo LA, Holanda MS, Ortiz F, Llorca J, Delgado-Rodríguez M. Impact of the surviving sepsis campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med 2010, 38:1036-1043. 10.1097/CCM.0b013e3181d455b6, 20154597.
28. Puskarich MA, Trzeciak S, Shapiro NI, rnold RC, Horton JM, Studnek JR, Kline JA, Jones AE, Emergency Medicine Shock Research Network (EMSHOCKNET) Emergency medicine shock research network (EMSHOCKNET): association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med 2011, 39:2066-2071. 10.1097/CCM.0b013e31821e87ab, 3158284, 21572327, Emergency Medicine Shock Research Network (EMSHOCKNET).
29. Riché FC, Dray X, Laisné MJ, Matéo J, Raskine L, Sanson-Le Pors MJ, Payen D, Valleur P, Cholley BP. Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care 2009, 13(3):R99. 10.1186/cc7931, 2717471, 19552799.
30. Fry D. The generic response. Crit Care Med 2008, 36:1369-1370. 10.1097/CCM.0b013e31816a11e9, 18379273.
31. Tang BM, McLean AS, Dawes IW, Huang SJ, Cowley MJ, Lin RC. Gene-expression profiling of gram-positive and gram-negative sepsis in critically ill patients. Crit Care Med 2008, 36:1125-1128. 10.1097/CCM.0b013e3181692c0b, 18379237.
32. Montravers P, Andremont A, Massias L, Carbon C. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J Infect Dis 1994, 169:821-830. 10.1093/infdis/169.4.821, 8133097.
33. Montravers P, Mohler J, Saint Julien L, Carbon C. Evidence of the proinflammatory role of enterococcus faecalis in polymicrobial peritonitis in rats. Infect Immun 1997, 65:144-149. 174568, 8975904.
34. Höffken G, Niederman M. Nosocomial pneumonia. The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002, 122:2183-2196. 10.1378/chest.122.6.2183, 12475862.
35. Rello J, Vidaur L, Sandiumenge A, Rodríguez A, Gualis B, Boque C, Diaz E. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 2004, 32:2183-2190.
36. Pea F, Viale P. Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock-does the dose matter?. Crit Care 2009, 13(3):214. 10.1186/cc7774, 2717408, 19519961.
37. Hatala R, Dinh T, Cook DJ. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 1996, 124:717-725. 10.7326/0003-4819-124-8-199604150-00003, 8633831.
38. McKenzie C. Antibiotic dosing in critical illness. J Antimicrob Chemother 2011, 66(Suppl 2):ii25-ii31.
39. Roberts JA, Lipman J, Blot S, Rello J. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Curr Opin Crit Care 2008, 14(4):390-396. 10.1097/MCC.0b013e3283021b3a, 18614901.
40. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010, 50(2):133-164. 10.1086/649554, 20034345.
41. Powell LL, Wilson SE. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection. Surg Infect (Larchmt) 2000, 1(1):57-63. 10.1089/109629600321308, 12594910.
42. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother 2009, 64(1):169-174. 10.1093/jac/dkp162, 2692504, 19435736.
43. Jones RN, Huynh HK, Biedenbach DJ, Fritsche TR, Sader HS. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations. J Antimicrob Chemother 2004, 54(1):144-154. 10.1093/jac/dkh298, 15190031.
44. Brown SD, Traczewski MM. Comparative in vitro antimicrobial activity of a new carbapenem, doripenem: tentative disc diffusion criteria and quality control. J Antimicrob Chemother 2005, 55(6):944-949. 10.1093/jac/dki134, 15872043.
45. Michalopoulos AS, Karatza DC. Multidrug-resistant Gram-negative infections: the use of colistin. Expert Rev Anti Infect Ther 2010, 8(9):1009-1017. 10.1586/eri.10.88, 20818945.
46. Papaparaskevas J, Tzouvelekis LS, Tsakris A, Pittaras TE, Legakis NJ. Hellenic tigecycline study group: in vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints. Diagn Microbiol Infect Dis 2010, 66(2):187-194. 10.1016/j.diagmicrobio.2009.09.012, 19836184.
47. Sekowska A, Gospodarek E. Susceptibility of Klebsiella spp. to tigecycline and other selected antibiotics. Med Sci Monit 2010, 16(6):BR193-BR196.
48. Stein GE, Babinchak T. Tigecycline: an update. Diagn Microbiol Infect Dis 2013, 75(4):331-336. 10.1016/j.diagmicrobio.2012.12.004, 23357291.
49. US Food and Drug Administration FDA drug safety communication: increased risk of death with Tygacil (tigecycline) compared to other antibiotics used to treat similar infections [online]. Available from URL: http://www.fda.gov/Drugs/DrugSafety/ucm224370.htm, US Food and Drug Administration.
50. Stein GE, Smith CL, Missavage A, Saunders JP, Nicolau DP, Battjes SM, Kepros JP. Tigecycline penetration into skin and soft tissue. Surg Infect (Larchmt) 2011, 12(6):465-467. 10.1089/sur.2011.022, 22136488.
51. Zonios DI, Bennett JE. Update on azole antifungals. Semin Respir Crit Care Med 2008, 29(2):198-210. 10.1055/s-2008-1063858, 18366001.
52. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007, 20:133-163. 10.1128/CMR.00029-06, 1797637, 17223626.
53. Glockner A. Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin: review of the literature. Eur J Med Res 2011, 16(4):167-179. 10.1186/2047-783X-16-4-167, 3352073, 21486731.
54. Chen SC, Slavin MA, Sorrell TC. Echinocandin antifungal drugs in fungal infections: a comparison. Drugs 2011, 71(1):11-41. 10.2165/11585270-000000000-00000, 21175238.
55. Ostrosky-Zeichner L, Rex JH, Pappas PG, Hamill RJ, Larsen RA, Horowitz HW, Powderly WG, Hyslop N, Kauffman CA, Cleary J, Mangino JE, Lee J. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother 2003, 47:3149-3154. 10.1128/AAC.47.10.3149-3154.2003, 201160, 14506023.
56. Karimova A, Pinsky DJ. The endothelial response to oxygen eprivation: biology and clinical implications. Intensive Care Med 2001, 27:19-31. 10.1007/s001340000790, 11280633.
57. Benjamin E, Leibowitz AB, Oropello J, Iberti TJ. Systemic hypoxic and inflammatory syndrome: An alternative designation for " sepsis syndrome" Crit Care Med 1992, 20:680-682. 10.1097/00003246-199205000-00022, 1572194.
58. Rivers E. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Eng J Med 2001, 345:1368-1377.
59. Aduen J, Bernstein WK, Khastgir T, Miller J, Kerzner R, Bhatiani A, Miller J, Kerzner R, Bhatiani A, Lustgarten J, Bassin AS, Davison L, Chernow B. The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. JAMA 1994, 272:1678-1685. 10.1001/jama.1994.03520210062033, 7966896.
60. Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Bellamy SL, Christie JD. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009, 37:1670-1677. 10.1097/CCM.0b013e31819fcf68, 19325467.
61. Trzeciak S, Dellinger RP, Chansky ME, Arnold RC, Schorr C, Milcarek B, Hollenberg SM, Parrillo JE. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med 2007, 33:970-977. 10.1007/s00134-007-0563-9, 17431582.
62. Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, Weiss JW. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 2005, 45:524-528. 10.1016/j.annemergmed.2004.12.006, 15855951.
63. Pearse RM. Extending the role of lactate measurement into the prehospital environment. Crit Care 2009, 13:115. 10.1186/cc7687, 2688110, 19232076.
64. Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, Tomlanovich MC. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004, 32:1637-1642. 10.1097/01.CCM.0000132904.35713.A7, 15286537.
65. James JH, Luchette FA, McCarter FD, Fischer JE. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 1999, 354:505-508. 10.1016/S0140-6736(98)91132-1, 10465191.
66. Dugas D, Mackenhauer J, Joyce N, Donnino M. Prevalence and characteristics of nonlactate and lactate expressors in septic shock. Crit Care Med 2009, 37(Suppl):A227.
67. Cannon CM, for the Multicenter Severe S, Septic Shock Collaborative G. The GENESIS Project (GENeralization of Early Sepsis InterventionS) A multicenter quality improvement collaborative. Acad Emerg Med 2010, 17:1258. for the Multicenter Severe S, Septic Shock Collaborative G. The GENESIS Project (GENeralization of Early Sepsis InterventionS).
68. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2011, 3:CD000567.
69. Walker J, Criddle LM. Pathophysiology and management of abdominal compartment syndrome. Am J Crit Care 2003, 12(4):367-371.
70. Brandt S, Regueira T, Bracht H, Porta F, Djafarzadeh S, Takala J, Gorrasi J, Borotto E, Krejci V, Hiltebrand LB, Bruegger LE, Beldi G, Wilkens L, Lepper PM, Kessler U, Jakob SM. Effect of fluid resuscitation on mortality and organ function in experimental sepsis models. Crit Care 2009, 13(6):R186. 10.1186/cc8179, 2811934, 19930656.
71. Harvey S, Young D, Brampton W, Cooper AB, Doig G, Sibbald W, Rowan K. Pulmonary artery catheters for adult patients in intensive care. Cochrane Database Syst Rev 2006, 19(3). CD003408.
72. Charron C, Caille V, Jardin F, Vieillard-Baron A. Echocardiographic measurement of fluid responsiveness. Curr Opin Crit Care 2006, 12(3):249-254. 10.1097/01.ccx.0000224870.24324.cc, 16672785.
73. Manasia AR, Nagaraj HM, Kodali RB, Croft LB, Oropello JM, Kohli-Seth R, Leibowitz AB, DelGiudice R, Hufanda JF, Benjamin E, Goldman ME. Feasibility and potential clinical utility of goal-directed transthoracic echocardiography performed by noncardiologist intensivists using a small hand-carried device (SonoHeart) in critically ill patients. J Cardiothorac Vasc Anesth 2005, 19(2):155-9. 10.1053/j.jvca.2005.01.023, 15868520.
74. Zhang Z, Xu X, Yao M, Chen H, Ni H, Fan H. Use of the PiCCO system in critically ill patients with septic shock and acute respiratory distress syndrome: a study protocol for a randomized controlled trial. Trials 2013, 14:32. 10.1186/1745-6215-14-32, 3563511, 23374652.
75. Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?. Chest 1993, 103(6):1826-1831. 10.1378/chest.103.6.1826, 8404107.
76. de Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med 2012, 40(3):725-730. 10.1097/CCM.0b013e31823778ee, 22036860.
77. Regnier B, Rapin M, Gory G, Lemaire F, Teisseire B, Harari A. Haemodynamic effects of dopamine in septic shock. Intensive Care Med 1977, 3:47-53. 10.1007/BF01683060, 893773.
78. Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, Mallédant Y. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 2002, 71:381-388. 10.1067/mcp.2002.122471, 12011824.
79. Myburgh JA, Higgins A, Jovanovska A, CAT Study investigators A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008, 34:2226-2234. 10.1007/s00134-008-1219-0, 18654759, CAT Study investigators.
80. Holmes CL, Patel BM, Russell JA, Walley KR, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001, 120:989-1002. 10.1378/chest.120.3.989, 11555538.
81. White LE, Hassoun HT, Bihorac A, Moore LJ, Sailors RM, McKinley BA, Valdivia A, Moore FA. Acute kidney injury is surprisingly common and a powerful predictor of mortality in surgical sepsis. J Trauma Acute Care Surg 2013, 75(3):432-438. 10.1097/TA.0b013e31829de6cd, 24089113.
82. Marshall JC. Principles of source control in the early management of sepsis. Curr Infect Dis Rep 2010, 12(5):345-353. 10.1007/s11908-010-0126-z, 21308516.
83. Marshall JC, al Naqbi A. Principles of source control in the management of sepsis. Crit Care Clin 2009, 25(4):753-768. 10.1016/j.ccc.2009.08.001, 19892251.
84. Wacha H, Hau T, Dittmer R, Ohmann C. Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis study group. langenbecks Arch Surg 1999, 384:24-32. 10.1007/s004230050169, 10367626.
85. Sugimoto K, Hirata M, Kikuno T, Takishima T, Maekawa K, Ohwada T. Large-volume intraoperative peritoneal lavage with an assistant device for treatment of peritonitis caused by blunt traumatic rupture of the small bowel. J Trauma 1995, 39(4):689-692. 10.1097/00005373-199510000-00013, 7473956.
86. Lopez N, Kobayashi L, Coimbra R. A Comprehensive review of abdominal infections. World J Emerg Surg 2011, 6:7. 10.1186/1749-7922-6-7, 3049134, 21345232.
87. Agresta F, Ciardo LF, Mazzarolo G, Michelet I, Orsi G, Trentin G, Bedin N. Peritonitis: laparoscopic approach. World J Emerg Surg 2006, 24:1-9.
88. Anderson ID, Fearon KC, Grant IS. Laparotomy for abdominal sepsis in the critically ill. Br J Surg 1996, 83(4):535-539. 10.1002/bjs.1800830434, 8665253.
89. Koperna T, Semmler D, Marian F. Risk stratification in emergency surgical patients: is the APACHE II score a reliable marker of physiological impairment?. Arch Surg 2001, 136(1):55-59. 10.1001/archsurg.136.1.55, 11146778.
90. van Ruler O, Kiewiet JJ, Boer KR, Lamme B, Gouma DJ, Boermeester MA, Reitsma JB. Failure of available scoring systems to predict ongoing infection in patients with abdominal sepsis after their initial emergency laparotomy. BMC Surg 2011, 23:11-38.
91. Koperna T, Schulz F. Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection. World J Surg 2000, 24(1):32-37. 10.1007/s002689910007, 10594200.
92. van Ruler O, Lamme B, de Vos R, Obertop H, Reitsma JB, Boermeester MA. Decision making for relaparotomy in secondary peritonitis. Dig Surg 2008, 25(5):339-346. 10.1159/000158911, 18827489.
93. Lamme B, Mahler CW, van Ruler O, Gouma DJ, Reitsma JB, Boermeester MA. Clinical predictors of ongoing infection in secondary peritonitis: systematic review. World J Surg 2006, 30(12):2170-2181. 10.1007/s00268-005-0333-1, 17102920.
94. Hinsdale JG, Jaffe BM. Re-operation for intra-abdominal sepsis. Indications and results in modern critical care setting. Ann Surg 1984, 199(1):31-36. 10.1097/00000658-198401000-00006, 1353254, 6691729.
95. Hutchins RR, Gunning MP, Lucas DN, Allen-Mersh TG, Soni NC. Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery. World J Surg 2004, 28(2):137-141. 10.1007/s00268-003-7067-8, 14708056.
96. van Ruler O, Lamme B, Gouma DJ, Reitsma JB, Boermeester MA. Variables associated with positive findings at relaparotomy in patients with secondary peritonitis. Crit Care Med 2007, 35(2):468-476. 10.1097/01.CCM.0000253399.03545.2D, 17205025.
97. Holzheimer RG, Gathof B. Re-operation for complicated secondary peritonitis-how to identify patients at risk for persistent sepsis. Eur J Med Res 2003, 8(3):125-134.
98. van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA. Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 2007, 298:865-872. 10.1001/jama.298.8.865, 17712070.
99. Robledo FA, Luque-de-León E, Suárez R, Sánchez P, de-la-Fuente M, Vargas A, Mier J. Open versus closed management of the abdomen in the surgical treatment of severe secondary peritonitis: a randomized clinical trial. Surg Infect (Larchmt) 2007, 8:63-72. 10.1089/sur.2006.8.016, 17381398.
100. Kirkpatrick AW, Roberts DJ, de Waele J, Jaeschke R, Malbrain ML, de Keulenaer B, Duchesne J, Bjorck M, Leppaniemi A, Ejike JC, Sugrue M, Cheatham M, Ivatury R, Ball CG, Reintam Blaser A, Regli A, Balogh ZJ, D'Amours S, Debergh D, Kaplan M, Kimball E, Olvera C. Pediatric Guidelines Sub-Committee for the World Society of the Abdominal Compartment Syndrome. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med 2013, 39(7):1190-1206. 10.1007/s00134-013-2906-z, 3680657, 23673399.
101. Merrell RC. The abdomen as source of sepsis in critically ill patients. Crit Care Clin 1995, 11(2):255-272.
102. Waibel BH, Rotondo MF. Damage control in trauma and abdominal sepsis. Crit Care Med 2010, 38(9 Suppl):S421-S430.
103. Jansen JO, Loudon MA. Damage control surgery in a non-trauma setting. Br J Surg 2007, 94(7):789-790. 10.1002/bjs.5922, 17571297.
104. Amin AI, Shaikh IA. Topical negative pressure in managing severe peritonitis: a positive contribution?. World J Gastroenterol 2009, 15(27):3394-3397. 10.3748/wjg.15.3394, 2712900, 19610140.
105. Schmelzle M, Alldinger I, Matthaei H, Aydin F, Wallert I, Eisenberger CF, Schulte Am Esch J, Dizdar L, Topp SA, Yang Q, Knoefel WT. Long-term vacuum-assisted closure in open abdomen due to secondary peritonitis: a retrospective evaluation of a selected group of patients. Dig Surg 2010, 27(4):272-278. 10.1159/000314609, 20664203.
106. Schein M. Planned reoperations and open management in critical intra-abdominal infections: prospective experience in 52 cases. World J Surg 1991, 15:537-545. 10.1007/BF01675658, 1832509.
107. Adkins AL, Robbins J, Villalba M, Bendick P, Shanley CJ. Open abdomen management of intra-abdominal sepsis. Am Surg 2004, 70:137-140.
108. Horwood J, Akbar F, Maw A. Initial experience of laparostomy with immediate vacuum therapy in patients with severe peritonitis. Ann R Coll Surg Engl 2009, 91(8):681-687. 10.1308/003588409X12486167520993, 2966252, 19785944.
109. Demetriades D. Total management of the open abdomen. Int Wound J 2012, 9(Suppl 1):17-24.
110. Paul JS, Ridolfi TJ. A case study in intra-abdominal sepsis. Surg Clin North Am 2012, 92(6):1661-1677. 10.1016/j.suc.2012.08.014, 23153889.
111. Rotondo MF, Schwab CW, McGonigal MD, Phillips GR, Fruchterman TM, Kauder DR, Latenser BA, Angood PA. 'Damage control': an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 1993, 35(3):375-382. 10.1097/00005373-199309000-00008, 8371295.
112. Godat L, Kobayashi L, Costantini T, Coimbra R. Abdominal damage control surgery and reconstruction: World society of emergency surgery position paper. World J Emerg Surg 2013, 8(1):53. 10.1186/1749-7922-8-53, 3878509, 24341602.
113. Waibel BH, Rotondo MM. Damage control surgery: it's evolution over the last 20 years. Rev Col Bras Cir 2012, 39(4):314-321. 10.1590/S0100-69912012000400012, 22936231.
114. Moore LJ, Moore FA. Epidemiology of sepsis in surgical patients. Surg Clin North Am 2012, 92(6):1425-1443. 10.1016/j.suc.2012.08.009, 23153877.
115. Ordoñez CA, Pino LF, Badiel M, Sánchez AI, Loaiza J, Ballestas L, Puyana JC. Safety of performing a delayed anastomosis during damage control laparotomy in patients with destructive colon injuries. J Trauma 2011, 71(6):1512-1517. 10.1097/TA.0b013e31823d0691, 3413258, 22182861.
116. Ordonez CA, Sanchez AI, Pineda JA, Badiel M, Mesa R, Cardona U, Arias R, RossoF, Granados M, Gutiérrez-Martínez MI, Ochoa JB, Peitzman A, Puyana JC. Deferred primary anastomosis versus diversion in patients with severe secondary peritonitis managed with staged laparotomies. World J Surg 2010, 34:169-176. 10.1007/s00268-009-0285-y, 3413282, 20020299.
117. Perathoner A, Klaus A, Muhlmann G, Oberwalder M, Margreiter R, Kafka-Ritsch, Oberwalder M, Margreiter R, Kafka-Ritsch Q. Damage control with abdominal vacuum therapy (VAC) to manage perforated diverticulitis with advanced generalized peritonitis - a proof of concept. Int J Colorectal Dis 2010, 25:767-774. 10.1007/s00384-010-0887-8, 20148255.
118. Kafka-Ritsch R, Birkfellner F, Perathoner A, Raab H, Nehoda H, Pratschke J, Zitt M. Damage control surgery with abdominal vacuum and delayed bowel reconstruction in patients with perforated diverticulitis Hinchey III/IV. J Gastroenterol Surg 2012, 16:1915-1922.
119. Yuan Y, Ren J, He Y. Current status of the open abdomen treatment for intra-abdominal infection. Gastroenterol Res Pract 2013, 532013. Epub 2013 Oct 2.
120. Regner JL, Kobayashi L, Coimbra R. Surgical strategies for management of the open abdomen. World J Surg 2012, 36(3):497-510. 10.1007/s00268-011-1203-7, 21847684.
121. Padalino P, Dionigi G, Minoja G, Carcano G, Rovera F, Boni L, Dionigi R. Fascia-to-fascia closure with abdominal topical negative pressure for severe abdominal infections: preliminary results in a department of general surgery and intensive care unit. Surg Infect (Larchmt) 2010, 11(6):523-528. 10.1089/sur.2010.042, 20969470.
122. Tsuei BJ, Skinner JC, Bernard AC, Kearney PA, Boulanger BR. The open peritoneal cavity: etiology correlates with the likelihood of fascial closure. Am Surg 2004, 70(7):652-656.
123. Pliakos I, Papavramidis TS, Mihalopoulos N, Koulouris H, Kesisoglou I, Sapalidis K, Deligiannidis N, Papavramidis S. Vacuum-assisted closure in severe abdominal sepsis with or without retention sutured sequential fascial closure: a clinical trial. Surgery 2010, 148(5):947-953. 10.1016/j.surg.2010.01.021, 20227097.
124. Roberts DJ, Zygun DA, Grendar J, Ball CG, Robertson HL, Ouellet JF, Cheatham ML, Kirkpatrick AW. Negative-pressure wound therapy for critically ill adults with open abdominal wounds: a systematic review. J Trauma Acute Care Surg 2012, 73(3):629-639. 10.1097/TA.0b013e31825c130e, 22929494.
125. Kubiak BD, Albert SP, Gatto LA, Snyder KP, Maier KG, Vieau CJ, Roy S, Nieman GF. Peritoneal negative pressure therapy prevents multiple organ injury in a chronic porcine sepsis and ischemia/reperfusion model. Shock 2010, 34:525-534. 10.1097/SHK.0b013e3181e14cd2, 20823698.
126. Plaudis H, Rudzats A, Melberga L, Kazaka I, Suba O, Pupelis G. Abdominal negative-pressure therapy: a new method in countering abdominal compartment and peritonitis - prospective study and critical review of literature. Ann Intensive Care 2012, 20(2 Suppl 1):S23.
127. Boele van Hensbroek P, Wind J, Dijkgraaf MG, Busch OR, Goslings JC. Temporary closure of the open abdomen: a systematic review on delayed primary fascial closure in patients with an open abdomen. World J Surg 2009, 33(2):199-207. 10.1007/s00268-008-9867-3, 3259401, 19089494.
128. Rasilainen SK, Mentula PJ, Leppäniemi AK. Vacuum and mesh-mediated fascial traction for primary closure of the open abdomen in critically ill surgical patients. Br J Surg 2012, 99(12):1725-1732. 10.1002/bjs.8914, 23034811.
129. Kissane NA, Itani KM. A decade of ventral incisional hernia repairs with biologic acellular dermal matrix: what have we learned?. Plast Reconstr Surg 2012, 130(5 Suppl 2):194S-202S.
130. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine Japanese Society of Intensive Care Medicine Society of Critical Care Medicine Society of Hospital Medicine Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine Japanese Society of Intensive Care Medicine Society of Critical Care Medicine Society of Hospital Medicine Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine.
131. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001, 11236773.
132. Hodder RV, Hall R, Russell JA, Fisher HN, Lee B. Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort. Crit Care 2009, 13(3):R78. 10.1186/cc7893, 2717441, 19457240.
133. Finfer S, Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Gårdlund B, Marshall JC, Rhodes A. Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock. Intensive Care Med 2008, 34(11):1935-1947. 10.1007/s00134-008-1266-6, 2995439, 18839141.
134. Savel RH, Munro CL. Evidence-based backlash: the tale of drotrecogin alfa. Am J Crit Care 2012, 21(2):81-83. 10.4037/ajcc2012903, 22381983.
135. Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, de Gaudio R, Keh D, Kupfer Y, Oppert M, Meduri GU. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009, 301(22):2362-2375. 10.1001/jama.2009.815, 19509383.
136. Annane D. Corticosteroids for severe sepsis: an evidence-based guide for physicians. Ann Intensive Care 2011, 1(1):7. 10.1186/2110-5820-1-7, 3224490, 21906332.
137. Cohen J, Chin W. Nutrition and sepsis. World Rev Nutr Diet 2013, 105:116-125.
138. Marik PE, Zaloga GP. Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med 2001, 29:2264-2270. 10.1097/00003246-200112000-00005, 11801821.
139. Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P. Canadian critical care clinical practice guidelines committee: Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 2003, 27:355-373. 10.1177/0148607103027005355, 12971736.
140. Doig GS, Heighes PT, Simpson F, Sweetman EA, Davies AR. Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive Care Med 2009, 35:2018-2027. 10.1007/s00134-009-1664-4, 19777207.